JARAZO Javier Martin,WALTER Jonas,SCHWAMBORN Jens Christian
申请号：
LU100797
公开号：
LU100797B1
申请日:
2018.05.15
申请国别(地区):
LU
年份:
2019
代理人:
摘要：
The present invention relates to 2-hydroxypropyl-β-cyclodextrin for use in a method of treatment of a parkinsonian condition selected from the group consisting of: Parkinson's disease, Parkinsonism and Parkinson-plus syndrome as well as methods and uses based thereon. The present invention further relates to an isolated dopaminergic neuron or an isolated precursor cell thereof exposed to 2-hydroxypropyl-β-cyclodextrin as well as methods and uses based thereon.
